Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy, Gastric and Esophageal

Ken Kato

MD, PhD

🏢National Cancer Center Hospital, Tokyo🌐Japan

Chief, Department of Head and Neck, Esophageal Medical Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ken Kato leads esophageal and head and neck medical oncology at the National Cancer Center Hospital in Tokyo and contributed to CheckMate-648 and perioperative nivolumab studies in esophageal squamous cell carcinoma. His work anchors Japanese upper GI immunotherapy development. He integrates chemoradiation with IO.

Share:

🧪Research Fields 研究领域

esophageal squamous cell
CheckMate-648
Japanese esophageal trials
nivolumab esophageal
perioperative IO

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ken Kato 的研究动态

Follow Ken Kato's research updates

留下邮箱,当我们发布与 Ken Kato(National Cancer Center Hospital, Tokyo)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment